Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
09
A new U.S. study has shown that green tea may help reduce the risk of oral cancer, although scientists are reluctant to officially endorse green tea as an effective way of cancer prevention.
Genmab A/S announced today the initiation of a Phase III study of Arzerra (TM) ofatumumab plus chemotherapy versus rituximab plus chemotherapy to treat patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
This month marks three years since physicians began offering SAVI(TM) radiation treatment as part of breast conservation therapy for early- stage breast cancer -- a major milestone in breast brachytherapy.
08
As he fought the brain cancer that killed him Aug. 25, Sen. Edward Kennedy received proton radiation treatment at Massachusetts General Hospital. People asked me when Sen. Kennedy died, 'What did it (proton therapy) buy him? said Leonard Arzt, executive director of the National Association for Proton Therapy in Washington, D.C.
06
One of Australia's proudest scientific achievements of recent years, the vaccine against cervical cancer, may turn out to even more important than anyone Research published in the British Journal or" Cancer suggests that the vaccine may also prevent some breast cancers.
Mouth cancer (also called oral cancer) is a malignant growth which can occur in any part of the mouth including the lips and tongue. In the UK, the numbers of new cases have risen by over 41 per cent over the last ten years(1). About 5,325 people get cancer of the mouth each year and the disease kills one person every five hours. Treated in its early stages, mouth cancer is curable but if not detected early, it kills around one in two sufferers.
Drugs used to treat psychiatric disorders are highly effective at killing cancer cells, opening up potential new lines of treatments. Dr Louise Lurze-Mann of the University of NSW School of Biotechnology and Biomolecular Sciences was talking with psychiatric researchers at the University of Queensland when they mentioned that people with diseases like schizophrenia appear to have low rates of cancer, despite being more inclined to smoke than the general population.
Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases.
05
Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies. The data are being presented at the International Society for Biological Therapy of Cancer 2009 Annual Meeting.
In a review article published this month in The Oncologist, UNC's Dr. Richard M. Goldberg and a team of colleagues catalogue how the data collected in a single large comparative clinical trial testing combination chemotherapy for metastatic colorectal cancer has been used not only to benefit the patients that enrolled but also patients who subsequently developed the disease.
We care about your feedback. Let us know how we can improve your CancerCompass experience.